TY  - JOUR
AU  - de Koning,HJ
AU  - Luján Galán, Marcos
AU  - Etzioni,R
PY  - 2017
DO  - 10.1002/cncr.31178
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/116484
T2  - Cancer
AB  - Background: The European Randomized Study of Screening for Prostate Cancer (ERSPC) demonstrated that prostate-specific antigen (PSA) screening significantly reduced prostate cancer mortality (rate ratio, 0.79; 95% confidence interval, 0.69-0.91). The...
LA  - eng
M2  - 1197
PB  - Wiley
KW  - modeling
KW  - mortality reduction
KW  - prostate cancer
KW  - prostate-specific antigen (PSA) screening
TI  - The efficacy of prostate-specific antigen screening: impact of key components in the erspc and plco trials.
TY  - journal article
VL  - 124
ER  -